FDA panel gives cautious nod to the Watchman 3

The FDA’s Circulatory System Devices Panel voted 7-5 in favor of the Watchman, an implantable device that blocks the left atrial appendage with a fabric-covered expandable nitinol cage. It is designed to help patients with nonvalvular AF avoid warfarin therapy.

You can read a Heartwire story, a MedPage story, or a Reuters story.

You can read links to additonal coverage about the device in our previous story.